Emicizumab
ATC B02BX06 · 9 markets · 36 records
US 6 records · 6 strengths
CA 6 records · 6 strengths
GB 5 records · 5 strengths
- 150 mg/1 mLinjectionHemlibra 30mg/1ml solution for injection vials
- 105 mg/0.7 mLinjectionHemlibra 30mg/1ml solution for injection vials
- 60 mg/0.4 mLinjectionHemlibra 30mg/1ml solution for injection vials
- 30 mg/1 mLinjectionHemlibra 30mg/1ml solution for injection vials
- 12 mg/0.4 mLinjectionHemlibra 30mg/1ml solution for injection vials
AU 5 records · 5 strengths
- 30 mginjectionHEMLIBRA emicizumab (rch) 105 mg/0.7 mL solution for injection vial
- 150 mginjectionHEMLIBRA emicizumab (rch) 105 mg/0.7 mL solution for injection vial
- 105 mginjectionHEMLIBRA emicizumab (rch) 105 mg/0.7 mL solution for injection vial
- 60 mginjectionHEMLIBRA emicizumab (rch) 105 mg/0.7 mL solution for injection vial
Records without a stated strength · 1 Hemlibra
ES 5 records · 2 strengths
HK 4 records · 1 strengths
Records without a stated strength · 1 HEMLIBRA SOLUTION FOR INJECTION 105MG/0.7ML
SG 2 records · 2 strengths
- 150 mg/mLinjectionHEMLIBRA SOLUTION FOR INJECTION 30MG/ML
- 30 mg/mLinjectionHEMLIBRA SOLUTION FOR INJECTION 30MG/ML
TW 2 records · 2 strengths
- 30 mginjectionHEMLIBRA SC Injection 30 mg/mL血甯博皮下注射劑30毫克/毫升
Records without a stated strength · 1 HEMLIBRA SC Injection 30 mg/mL、血甯博皮下注射劑150毫克/毫升
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Hemlibra
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 30 mg injection | Hemlibra | HEMLIBRA emicizumab (rch) 105 mg/0.7 mL solution for injection vial | HEMLIBRA SC Injection 30 mg/mL 血甯博皮下注射劑30毫克/毫升 | ||||||
| 150 mg injection | Hemlibra | HEMLIBRA emicizumab (rch) 105 mg/0.7 mL solution for injection vial | |||||||
| 150 mg/1 mL injection | Hemlibra 30mg/1ml solution for injection vials | Hemlibra | |||||||
| 105 mg/0.7 mL injection | Hemlibra | Hemlibra 30mg/1ml solution for injection vials | |||||||
| 60 mg/0.4 mL injection | Hemlibra | Hemlibra 30mg/1ml solution for injection vials | |||||||
| 30 mg/1 mL injection | Hemlibra 30mg/1ml solution for injection vials | Hemlibra | |||||||
| 12 mg/0.4 mL injection | Hemlibra | Hemlibra 30mg/1ml solution for injection vials | |||||||
| 150 mg liquid | Hemlibra | ||||||||
| 150 mg/1 mL liquid | Hemlibra | ||||||||
| 105 mg liquid | Hemlibra | ||||||||
| 60 mg liquid | Hemlibra | ||||||||
| 30 mg liquid | Hemlibra | ||||||||
| 12 mg liquid | Hemlibra | ||||||||
| 300 mg/2 mL injection | Hemlibra | ||||||||
| 150 mg/mL injection | HEMLIBRA SOLUTION FOR INJECTION 30MG/ML | ||||||||
| 105 mg injection | HEMLIBRA emicizumab (rch) 105 mg/0.7 mL solution for injection vial | ||||||||
| 60 mg injection | HEMLIBRA emicizumab (rch) 105 mg/0.7 mL solution for injection vial | ||||||||
| 30 mg/mL injection | HEMLIBRA SOLUTION FOR INJECTION 30MG/ML | ||||||||
unknown | Hemlibra | HEMLIBRA SOLUTION FOR INJECTION 105MG/0.7ML | Hemlibra | ||||||
injection | HEMLIBRA SC Injection 30 mg/mL 血甯博皮下注射劑150毫克/毫升 |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
5 more strength/form rows are recorded only in GB · SG · ES · TW and are not shown in this table. Hay 5 filas de concentración/forma registradas solo en GB · SG · ES · TW que no se muestran en esta tabla. 另有 5 个规格/剂型仅在 GB · SG · ES · TW 有记录(未在本表显示)。 另有 5 個規格/劑型僅在 GB · SG · ES · TW 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.